Get access

Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes

Authors

  • C-C. Chi,

    1. Nuffield Department of Clinical Medicine, University of Oxford and Department of Dermatology, Churchill Hospital, Oxford OX3 7LJ, U.K.
    2. Department of Dermatology, Chang Gung Memorial Hospital Chiayi, Chang Gung University College of Medicine, Chiayi, Taiwan
    Search for more papers by this author
  • S-H. Wang,

    1. Nuffield Department of Clinical Medicine, University of Oxford and Department of Dermatology, Churchill Hospital, Oxford OX3 7LJ, U.K.
    2. Department of Dermatology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei and Department of Cosmetic Science, Chang Gung Institute of Technology, Taoyuan, Taiwan
    Search for more papers by this author
  • R. Charles-Holmes,

    1. Department of Dermatology, Warwick Hospital, Warwick, U.K.
    Search for more papers by this author
  • C. Ambros-Rudolph,

    1. Department of Dermatology, Medical University of Graz, Graz, Austria
    Search for more papers by this author
  • J. Powell,

    1. Department of Dermatology, North Hampshire Hospital, Basingstoke, U.K.
    Search for more papers by this author
  • R. Jenkins,

    1. Department of Dermatology, West Suffolk Hospital, Bury St Edmunds, U.K.
    2. St John’s Institute of Dermatology, St Thomas’ Hospital, London, U.K.
    Search for more papers by this author
  • M. Black,

    1. St John’s Institute of Dermatology, St Thomas’ Hospital, London, U.K.
    Search for more papers by this author
  • F. Wojnarowska

    1. Nuffield Department of Clinical Medicine, University of Oxford and Department of Dermatology, Churchill Hospital, Oxford OX3 7LJ, U.K.
    Search for more papers by this author

  • Conflicts of interest
    None declared.

Shu-Hui Wang.
E-mail: dermawang@hotmail.com;chingchi@cgmh.org.tw

Summary

Background  It is unclear whether clinical features of pemphigoid gestationis (PG), such as timing of onset and severity, may affect pregnancy outcomes or whether the adverse outcomes in pregnancies complicated by PG are related to or worsened by systemic corticosteroid treatment.

Objectives  To evaluate the associations of adverse pregnancy outcomes with clinical features, autoantibody titre of PG, and systemic corticosteroid treatment.

Methods  We conducted a retrospective cohort study recruiting 61 pregnancies complicated by PG from the St John’s Institute of Dermatology database which enrolled cases from dermatologists across the U.K., and two tertiary hospitals in the U.K. and Taiwan. Outcome measures included gestational age at delivery, preterm birth, birthweight, low birthweight (LBW, i.e. birthweight < 2500 g), small-for-gestational-age (i.e. birthweight below the 10th percentile for gestational age), fetal loss, congenital malformation, and mode of delivery.

Results  After controlling for maternal age and comorbidity, decreased gestational age at delivery was significantly associated with presence of blisters (= 0·017) and disease onset in the second trimester (= 0·001). Reduced birthweight was significantly associated with disease onset in the first and second trimesters (= 0·030 and 0·018, respectively) as was also LBW [adjusted odds ratio (95% confidence interval) 13·71 (1·22–154·59) and 10·76 (1·05–110·65), respectively]. No significant associations of adverse pregnancy outcomes with autoantibody titre or systemic corticosteroid treatment were found.

Conclusions  Onset of PG in the first or second trimester and presence of blisters may lead to adverse pregnancy outcomes including decreased gestational age at delivery, preterm birth, and LBW children. Such pregnancies should be considered high risk and appropriate obstetric care should be provided. Systemic corticosteroid treatment, in contrast, does not substantially affect pregnancy outcomes, and its use for PG in pregnant women is justified.

Ancillary